Healio Gastroenterology Current Issue

The following articles appeared in the print edition of Healio Gastroenterology.

Table of Contents

• Is FDA approval in sight for emerging EoE therapies? Monica Stonehill
• Alcohol-associated cirrhosis linked to higher mortality post-ICU discharge Monica Stonehill
• Group-based education improves symptom management, quality of life in celiac disease Kate Burba
• Libtayo effective in killing HCC tumors prior to resection Monica Stonehill
• Low FODMAP diet improves gastrointestinal symptoms in patients with celiac disease Lisa Holden
• Most liver transplant recipients mount adequate COVID-19 antibody response Anthony DeFino
• Open-label placebo reduces pain in pediatric, adolescent functional GI disorders Kate Burba
• Program eliminates gender disparities, boosts colonoscopy rates among Hispanic patients Monica Stonehill
• Q&A: Conquer communication disconnect to elevate IBD patient care Monica Stonehill
• Rectal indomethacin reduces post-procedural pancreatitis Kate Burba
• Salivary microRNA shows promise in detecting HCC Monica Stonehill
• Susceptibility to long-term COVID-19 complications linked to gut microbiome profile Monica Stonehill
• VIDEO: Barriers to PPI gastroprotection lead to underutilization among providers Jacob E. Kurlander, MD, MS; Monica Stonehill
• VIDEO: Changes in duodenal microbiome linked to aging Kate Burba; Ruchi Mathur, MD
• VIDEO: Microbiome Health Index predicts post-antibiotic dysbiosis Ken Blount, PhD; Kate Burba
• Exact Science second-generation Cologuard shows high sensitivity, improved specificity Georgia I Salvaryn
• FDA approves IDE application for novel polyp detection test Kate Burba
• Budesonide for EoE: Why the FDA denial is so hard to swallow Ikuo Hirano, MD
• COVID-19: Vaccines safe in IBD, more research needed on additional doses Monica Stonehill
• Digital health enhances clinical care, powers public health Kate Burba
• Expert advises: ‘We must treat first’ with Crohn’s perianal fistula complications Kate Burba
• IBD patients using specific carbohydrate diet report symptom improvement Monica Stonehill
• IBD therapies ‘still plateauing’ despite progress: Combining drugs may help break ceiling Robert Stott
• Machine learning model demonstrates ‘excellent distinction’ between active, inactive UC Robert Stott
• No benefit seen with 5ASA combined with corticosteroids for acute, severe UC Monica Stonehill
• Novel endpoint is ‘reliable’ for assessment of endoscopic improvement in Crohn’s Monica Stonehill
• Postoperative open abdomen creates highest risk for VTE in IBD patients Kate Burba
• Potential for FDA approval nears for emerging NASH therapies Monica Stonehill
• Real-time intestinal ultrasound images promote shared understanding in IBD patients Kate Burba
• Skyrizi effective, well tolerated during induction, maintenance in moderate to severe CD Monica Stonehill
• Starting Entyvio within ‘30 days of diagnosis’ improved treatment response in UC Robert Stott
• ‘We should be screening now’ for HDV with emerging drug therapies in phase 3 Robert Stott
• VIDEO: ‘Disruptive innovator’ aims to simplify diagnostics, care for GI patients Eric D. Shah, MD, MBA; Monica Stonehill
• VIDEO: IBD-related mental illness is ‘rarely discussed’ due to cultural stigmas Monica Stonehill
• VIDEO: Knowledge of food culture is key when treating IBD in South Asian patients Neha D. Shah, MPH, RD, CNSC, CHES; Monica Stonehill
• VIDEO: What’s in a name? How GI lesions carry the name Dieulafoy Monica Stonehill; Klaus Mergener, MD, PhD, MBA
• VIDEO: What’s in a name? The expert behind the Schatzki ring Klaus Mergener, MD, PhD, MBA; Monica Stonehill